Jeff Miller, OD
Optometrist · Tahlequah, OKNPI 1144240573
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.0%), consulting fees and grants — rather than concentrated in one kind of arrangement. Optovue, Inc. accounts for 98.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $38,769 and has fallen 99.6% since, to $157 in 2025. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $4185.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optovue, Inc.$66K
- Sun Pharmaceutical Industries Inc.$205
- Glaukos Corporation$200
- Lumibird Medical Inc.$157
- Alcon$93
- Bausch & Lomb, A Division Of Bausch Health US, LLC$92
- plus $30 from 2 others
What the payments were for
- Consulting fees$20,85531%
- Speaking & faculty fees$27,46041%
- Grants$18,07527%
- Food & beverage$5791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optovue, Inc. | 4 | $66,190 |
| Sun Pharmaceutical Industries Inc. | 4 | $205 |
| Glaukos Corporation | 1 | $200 |
| Lumibird Medical Inc. | 1 | $157 |
| Alcon | 2 | $93 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $92 |
| Optinose US, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AngioVue$38,730
- Solix$27,460
- KXL System$200
- CEQUA$158
How this compares
$66,969 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 28 | $232 |
| Brimonidine Tartrate | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Tahlequah
- Nathan LighthizerTahlequah$1M
- Charles WhittleTahlequah$28K
- Latricia PackTahlequah$25K
- Cindy ShanTahlequah$16K
- Jenna LighthizerTahlequah$14K
- Aubry TackettTahlequah$12K
- Charles RonanTahlequah$9K
- Ryan SwindellTahlequah$7K
- Andrea LasbyTahlequah$6K
- Selina McGeeEdmond$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.